Clinical Trial

A Study to Learn How Different Amounts of the Study Medicine Called PF-08642534 Are Tolerated and Act in the Body of People Who Have Obesity

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will look at a study drug called PF-08642534 in people with obesity (have too much body weight) to see: if participants can take different amounts (doses) of the study drug in a safe way and how adults with obesity tolerate it, and how the body handles the study drug (for example, how the study drug is absorbed and removed from the body). People who want to join the study will first go through a screening period of up to 4 weeks. Doctors will check if each person meets the study conditions, including age, body weight, and general health. People with certain medical conditions will not be able to take part in the study.
Trial Details
NCT Number NCT07731139
Lead Sponsor Pfizer
Conditions Obesity
Enrollment 120 participants
Start Date 2026-07-28
Primary Completion 2027-04-21 (estimated)
Study Completion 2027-04-21 (estimated)
Updated on ClinicalTrials.gov 2026-07-28